Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Carmen L. Zegarra-Urquia, Julio Santiago, Joel D. Bumgardner, Alexander K. Goroncy, José Vega-Baudrit, Claudia A. Hernández-Escobar & E. Armando Zaragoza-Contreras. (2024) Characterization of isoniazid incorporation into chitosan-poly(aspartic acid) nanoparticles. International Journal of Polymeric Materials and Polymeric Biomaterials 73:3, pages 190-199.
Read now
Read now
Sowmya Ramachandran, Priyanka Prakash, Noratiqah Mohtar, K. Sudesh Kumar & Thaigarajan Parumasivam. (2023) Review of inhalable nanoparticles for the pulmonary delivery of anti-tuberculosis drugs. Pharmaceutical Development and Technology 0:0, pages 1-14.
Read now
Read now
Sara Bahrainian, Mohammadreza Rouini & Kambiz Gilani. (2021) Preparation and evaluation of vancomycin spray-dried powders for pulmonary delivery. Pharmaceutical Development and Technology 26:6, pages 647-660.
Read now
Read now
Mohammed M Mehanna, Salma M Mohyeldin & Nazik A Elgindy. (2019) Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery. International Journal of Nanomedicine 14, pages 9089-9112.
Read now
Read now
Mahdieh Farhangi, Arash Mahboubi, Farzad Kobarfard, Alireza Vatanara & Seyed Alireza Mortazavi. (2019) Optimization of a dry powder inhaler of ciprofloxacin-loaded polymeric nanomicelles by spray drying process. Pharmaceutical Development and Technology 24:5, pages 584-592.
Read now
Read now
Shivalingappa Santhosh, Dhrubojyoti Mukherjee, Jayaraman Anbu, Manikanta Murahari & Banala Venkatesh Teja. (2019) Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies. Journal of Microencapsulation 36:4, pages 338-355.
Read now
Read now
Tulshidas S. Patil, Ashwini S. Deshpande, Shirish Deshpande & Pravin Shende. (2019) Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need. Journal of Drug Targeting 27:1, pages 12-27.
Read now
Read now
Piyush Mehta, C. Bothiraja, Shivajirao Kadam & Atmaram Pawar. (2018) Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages S791-S806.
Read now
Read now
Bably Khatun, Nibedita Banik, Anowar Hussain, Anand Ramteke & Tarun Maji. (2018) Genipin crosslinked curcumin loaded chitosan/montmorillonite K-10 (MMT) nanoparticles for controlled drug delivery applications. Journal of Microencapsulation 35:5, pages 439-453.
Read now
Read now
Diego Fontana de Andrade, Branko Vukosavljevic, Edilson Valmir Benvenutti, Adriana Raffin Pohlmann, Sílvia Stanisçuaski Guterres, Maike Windbergs & Ruy Carlos Ruver Beck. (2018) Redispersible spray-dried lipid-core nanocapsules intended for oral delivery: the influence of the particle number on redispersibility. Pharmaceutical Development and Technology 23:4, pages 414-425.
Read now
Read now
Tarun Garg, Amit K. Goyal, Goutam Rath & R. S. R. Murthy. (2016) Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation. Pharmaceutical Development and Technology 21:8, pages 951-960.
Read now
Read now
Ankur Bhardwaj, Shuchi Mehta, Shailendra Yadav, Sudheer K. Singh, Anne Grobler, Amit Kumar Goyal & Abhinav Mehta. (2016) Pulmonary delivery of antitubercular drugs using spray-dried lipid–polymer hybrid nanoparticles. Artificial Cells, Nanomedicine, and Biotechnology 44:6, pages 1544-1555.
Read now
Read now
P. Rajitha, Divya Gopinath, Raja Biswas, M. Sabitha & R. Jayakumar. (2016) Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases. Expert Opinion on Drug Delivery 13:8, pages 1177-1194.
Read now
Read now
Jagdeep Singh, Tarun Garg, Goutam Rath & Amit K. Goyal. (2016) Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review. Drug Delivery 23:5, pages 1676-1698.
Read now
Read now
Tarun Garg, Goutam Rath & Amit K. Goyal. (2016) Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis. Artificial Cells, Nanomedicine, and Biotechnology 44:3, pages 997-1001.
Read now
Read now
Md Iftekhar Ahmad, Suwipa Ungphaiboon & Teerapol Srichana. (2015) The development of dimple-shaped chitosan carrier for ethambutol dihydrochloride dry powder inhaler. Drug Development and Industrial Pharmacy 41:5, pages 791-800.
Read now
Read now
Paul Zarogoulidis, Ioannis Kioumis, Konstantinos Porpodis, Dionysios Spyratos, Kosmas Tsakiridis, Haidong Huang, Qiang Li, J Francis Turner, Robert Browning, Wolfgang Hohenforst-Schmidt & Konstantinos Zarogoulidis. (2013) Clinical experimentation with aerosol antibiotics: current and future methods of administration. Drug Design, Development and Therapy 7, pages 1115-1134.
Read now
Read now
Tomás Sou, MichelleP. McIntosh, LisaM. Kaminskas, RichardJ. Prankerd & DavidA. V. Morton. (2013) Designing a Multicomponent Spray-Dried Formulation Platform for Pulmonary Delivery of Biomacromolecules: The Effect of Polymers on the Formation of an Amorphous Matrix for Glassy State Stabilization of Biomacromolecules. Drying Technology 31:13-14, pages 1451-1458.
Read now
Read now
Articles from other publishers (84)
Bushra Tousian & Ali Reza Khosravi. (2023) Chitosan-based pulmonary particulate systems for anticancer and antiviral drug carriers: A promising delivery for COVID-19 vaccines. Results in Chemistry 6, pages 101146.
Crossref
Crossref
Mohit Kumar, Ayah R. Hilles, Samah Hamed Almurisi, Amit Bhatia & Syed Mahmood. (2023) Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations – A review. JCIS Open 12, pages 100095.
Crossref
Crossref
Eunice Chee & Andrés J. García. (2023) Biomaterial therapeutic strategies for treatment of bacterial lung infections. Biofilm 5, pages 100111.
Crossref
Crossref
Feng Ding, Guobin Qiu, Fengliang Tan, Tengyan Wu, Longzhen Ding, Xin Liu & Hongbin Zhong. (2023) Preparation and characterization of PEGylated magnetic ferrite with a biocompatible delivery for DOX. Applied Physics A 129:12.
Crossref
Crossref
Simpal Kumar Suman, Natarajan Chandrasekaran & C. George Priya Doss. (2023) Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments. Clinical Microbiology Reviews.
Crossref
Crossref
Popat Kumbhar, Jaskiran Kaur, Gabriele De Rubis, Keshav Raj Paudel, Parteek Prasher, Vyoma K Patel, Leander Corrie, Dinesh Kumar Chellappan, Gaurav Gupta, Sachin Kumar Singh, Vandana Patravale, John Disouza & Kamal Dua. (2023) Inhalation drug delivery in combating pulmonary infections: Advances and challenges. Journal of Drug Delivery Science and Technology 89, pages 105022.
Crossref
Crossref
Beatriz Behrend-Keim, Almendra Castro-Muñoz, Luis Monrreal-Ortega, Bárbara Ávalos-León, Carolina Campos-Estrada, Hugh D.C. Smyth, Tania F. Bahamondez-Canas & Daniel Moraga-Espinoza. (2023) The forgotten material: Highly dispersible and swellable gelatin-based microspheres for pulmonary drug delivery of cromolyn sodium and ipratropium bromide. International Journal of Pharmaceutics 644, pages 123331.
Crossref
Crossref
Sara Ahmed, Mai Mansour, Rania A.H. Ishak & Nahed D. Mortada. (2023) Customizable resveratrol spray-dried micro-composites for inhalation as a promising contender for treatment of idiopathic pulmonary fibrosis. International Journal of Pharmaceutics 642, pages 123117.
Crossref
Crossref
Danni Suhaidi, Yao-Da Dong, Paul Wynne, Karen P. Hapgood & David A. V. Morton. (2023) Bulk Flow Optimisation of Amorphous Solid Dispersion Excipient Powders through Surface Modification. Pharmaceutics 15:5, pages 1447.
Crossref
Crossref
Ardiyah Nurul Fitri Marzaman, Tri Puspita Roska, Sartini Sartini, Rifka Nurul Utami, Sulistiawati Sulistiawati, Cindy Kristina Enggi, Marianti A. Manggau, Latifah Rahman, Venkatram Prasad Shastri & Andi Dian Permana. (2023) Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration Routes. Antibiotics 12:5, pages 822.
Crossref
Crossref
Tom Bourguignon, Jesus Alfredo Godinez-Leon & Ruxandra Gref. (2023) Nanosized Drug Delivery Systems to Fight Tuberculosis. Pharmaceutics 15:2, pages 393.
Crossref
Crossref
Styliani Xiroudaki, Samuele Sabbatini, Camilla Pecoraro, Stella Cascioferro, Patrizia Diana, Nathalie Wauthoz, Cinzia Antognelli, Claudia Monari, Stefano Giovagnoli & Aurélie Schoubben. (2023) Development of a new indole derivative dry powder for inhalation for the treatment of biofilm-associated lung infections. International Journal of Pharmaceutics 631, pages 122492.
Crossref
Crossref
Morvarid Saeinasab, Mohamed Abdul-Al & Farshid Sefat. 2023. Principles of Biomaterials Encapsulation : Volume Two. Principles of Biomaterials Encapsulation : Volume Two
283
298
.
Piyush Pradeep Mehta & Vividha Dhapte-Pawar. 2023. Pulmonary Drug Delivery Systems: Material and Technological Advances. Pulmonary Drug Delivery Systems: Material and Technological Advances
213
245
.
Sanjoy Kumar Das, Soumalya Chakraborty, Sourav Bhowmik, Sudipta Roy & Yashwant Pathak. 2023. Tubercular Drug Delivery Systems. Tubercular Drug Delivery Systems
79
97
.
Kiran Dudhat & Harsha Patel. (2022) Preparation and evaluation of pirfenidone loaded chitosan nanoparticles pulmonary delivery for idiopathic pulmonary fibrosis. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Crossref
Nidhi Nainwal, Yuwanshi Sharma & Vikash Jakhmola. (2022) Dry powder inhalers of antitubercular drugs. Tuberculosis 135, pages 102228.
Crossref
Crossref
Leon J. Khoza, Pradeep Kumar, Admire Dube, Patrick H. Demana & Yahya E. Choonara. (2022) Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles. International Journal of Pharmaceutics 622, pages 121893.
Crossref
Crossref
Regina Scherließ, Simon Bock, Nicholas Bungert, Anna Neustock & Lena Valentin. (2022) Particle engineering in dry powders for inhalation. European Journal of Pharmaceutical Sciences 172, pages 106158.
Crossref
Crossref
Dipti Singh & Raghvendra Pratap Singh. 2022. Biogenic Sustainable Nanotechnology. Biogenic Sustainable Nanotechnology
357
372
.
Pooja Sanjay Khairnar, Ajit Singh & Rahul Shukla. 2022. Nanotechnology for Infectious Diseases. Nanotechnology for Infectious Diseases
387
417
.
Xiuhua Wang, Wei Wan, Jing Lu, Guilan Quan, Xin Pan & Peiqing Liu. (2021) Effects of L-leucine on the properties of spray-dried swellable microparticles with wrinkled surfaces for inhalation therapy of pulmonary fibrosis. International Journal of Pharmaceutics 610, pages 121223.
Crossref
Crossref
Zeeshan Ahmad Bhutta, Ayesha Kanwal, Moazam Ali, Muhammad Fakhar-e-Alam Kulyar, Wangyuan Yao, Muhammad Shoaib, Ambreen Ashar, Ashar Mahfooz, Misbah Ijaz, Nabeel Ijaz, Muhammad Asif, Shah Nawaz, Muhammad Raahim Mahfooz & Tahreem Kanwal. (2021) Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic. Nanotechnology 32:48, pages 482001.
Crossref
Crossref
Sunny Shah, Rohit Ghetiya, Moinuddin Soniwala & Jayant Chavda. (2021) Development and Optimization of Inhalable Levofloxacin Nanoparticles for The Treatment of Tuberculosis. Current Drug Delivery 18:6, pages 779-793.
Crossref
Crossref
Iago Dillion Lima Cavalcanti, Sandrelli Meridiana de Fátima Ramos dos Santos Medeiros, Daniel Charles dos Santos Macêdo, Isabella Macário Ferro Cavalcanti & Mariane Cajubá de Britto Lira Nogueira. (2021) Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19. Current Drug Delivery 18:5, pages 583-595.
Crossref
Crossref
Tivadar Feczkó. (2021) Polymeric nanotherapeutics acting at special regions of body. Journal of Drug Delivery Science and Technology 64, pages 102597.
Crossref
Crossref
Manasi M. Chogale, Sagar B. Dhoble & Vandana B. Patravale. (2021) A triple combination 'nano' dry powder inhaler for tuberculosis: in vitro and in vivo pulmonary characterization. Drug Delivery and Translational Research 11:4, pages 1520-1531.
Crossref
Crossref
Mohammad Zaidur Rahman Sabuj & Nazrul Islam. (2021) Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections. Nanoscale Advances 3:14, pages 4005-4018.
Crossref
Crossref
Jixian Zhang, Ping Zhan & Honglei Tian. (2021) Recent updates in the polysaccharides-based Nano-biocarriers for drugs delivery and its application in diseases treatment: A review. International Journal of Biological Macromolecules 182, pages 115-128.
Crossref
Crossref
Manasi M. Chogale, Sujay S. Gaikwad, Savita P. Kulkarni & Vandana B. Patravale. (2021) Quality-by-design Enabled Chitosan Nanoparticles for Antitubercular Therapy: Formulation, Statistical Optimization, and In Vitro Characterization. Current Drug Therapy 16:1, pages 64-82.
Crossref
Crossref
Ali Keshavarz, Hossam Kadry, Ahmed Alobaida, Md Nurunnabi & Taslim A. Al-Hilal. 2021. Bioinspired and Biomimetic Materials for Drug Delivery. Bioinspired and Biomimetic Materials for Drug Delivery
241
276
.
Sivaraj Mehnath & Murugaraj Jeyaraj. 2021. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy
59
89
.
Tamim Mosaiab, Dylan C. Farr, Milton J. Kiefel & Todd A. Houston. 2021. Comprehensive Glycoscience. Comprehensive Glycoscience
406
432
.
Zhi Ming Tan, Gui Ping Lai, Manisha Pandey, Teerapol Srichana, Mallikarjuna Rao Pichika, Bapi Gorain, Subrat Kumar Bhattamishra & Hira Choudhury. (2020) Novel Approaches for the Treatment of Pulmonary Tuberculosis. Pharmaceutics 12:12, pages 1196.
Crossref
Crossref
Mahwash Mukhtar, Edina Pallagi, Ildikó Csóka, Edit Benke, Árpád Farkas, Mahira Zeeshan, Katalin Burián, Dávid Kókai & Rita Ambrus. (2020) Aerodynamic properties and in silico deposition of isoniazid loaded chitosan/thiolated chitosan and hyaluronic acid hybrid nanoplex DPIs as a potential TB treatment. International Journal of Biological Macromolecules 165, pages 3007-3019.
Crossref
Crossref
Ruhisy Mohd Rasul, M. Tamilarasi Muniandy, Zabliza Zakaria, Kifayatullah Shah, Chin Fei Chee, Ali Dabbagh, Noorsaadah Abd Rahman & Tin Wui Wong. (2020) A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers. Carbohydrate Polymers 250, pages 116800.
Crossref
Crossref
Sina M. Matalqah, Khalid Aiedeh, Nizar M. Mhaidat, Karem H. Alzoubi, Yasser Bustanji & Islam Hamad. (2020) Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article. Current Drug Targets 21:15, pages 1613-1624.
Crossref
Crossref
Thaysa Ksiaskiewcz Karam, Sonia Ortega, Tania Ueda Nakamura, Rachel Auzély-Velty & Celso Vataru Nakamura. (2020) Development of chitosan nanocapsules containing essential oil of Matricaria chamomilla L. for the treatment of cutaneous leishmaniasis. International Journal of Biological Macromolecules 162, pages 199-208.
Crossref
Crossref
Iago Dillion Lima Cavalcanti & Mariane Cajubá de Britto Lira Nogueira. (2020) Pharmaceutical nanotechnology: which products are been designed against COVID-19?. Journal of Nanoparticle Research 22:9.
Crossref
Crossref
Stine Egebro Birk, Janus Anders Juul Haagensen, Helle Krogh Johansen, Søren Molin, Line Hagner Nielsen & Anja Boisen. (2020)
Microcontainer Delivery of Antibiotic Improves Treatment of
Pseudomonas aeruginosa
Biofilms
. Advanced Healthcare Materials 9:10.
Crossref
Crossref
Piyush P. Mehta, Atmaram P. Pawar, Kakasaheb R. Mahadik, Shivajirao S. Kadam & Vividha Dhapte‐Pawar. 2020. Polymer Coatings. Polymer Coatings
41
74
.
Jorge F. Pontes & Ana Grenha. (2020) Multifunctional Nanocarriers for Lung Drug Delivery. Nanomaterials 10:2, pages 183.
Crossref
Crossref
Mohsen Tafaghodi, Farzad Khademi, Farideh shiehzadeh & Zohreh Firouzi. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment
123
142
.
Damián Eduardo Pérez-Martínez & Roberto Zenteno-Cuevas. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment
37
52
.
Mónica P. A. Ferreira, João Pedro Martins, Jouni Hirvonen & Hélder A. Santos. 2020. Nanotechnology for Oral Drug Delivery. Nanotechnology for Oral Drug Delivery
253
284
.
Abdel Naser Dakkah, Yazan Bataineh, Bilal A Al Jaidi, Mohammad F. Bayan & Nabil A. Nimer. 2020. Integrative Nanomedicine for New Therapies. Integrative Nanomedicine for New Therapies
357
404
.
Tamim Mosaiab, Dylan C. Farr, Milton J. Kiefel & Todd A. Houston. (2019) Carbohydrate-based nanocarriers and their application to target macrophages and deliver antimicrobial agents. Advanced Drug Delivery Reviews 151-152, pages 94-129.
Crossref
Crossref
Adel Mohamed, Ayca Y. Pekoz, Kehinde Ross, Gillian A. Hutcheon & Imran Y. Saleem. (2019) Pulmonary delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for treatment of COPD. International Journal of Pharmaceutics 569, pages 118524.
Crossref
Crossref
Samia M. OmarNabila A. MaziadNourhan M. El-Tantawy. (2019) Pulmonary Delivery of Isoniazid in Nanogel-Loaded Chitosan Hybrid Microparticles for Inhalation. Journal of Aerosol Medicine and Pulmonary Drug Delivery 32:2, pages 78-87.
Crossref
Crossref
Margarida S. Miranda, Márcia T. Rodrigues, Rui M.A. Domingues, Egídio Torrado, Rui L. Reis, Jorge Pedrosa & Manuela E. Gomes. (2018) Exploring inhalable polymeric dry powders for anti-tuberculosis drug delivery. Materials Science and Engineering: C 93, pages 1090-1103.
Crossref
Crossref
Ting Wu, Weiping Liao, Wei Wang, Jie Zhou, Weiguo Tan, Weibing Xiang, Jinglin Zhang, Lina Guo, Tao Chen, Dong Ma, Weiye Yu & Xiang Cai. (2018) Genipin-crosslinked carboxymethyl chitosan nanogel for lung-targeted delivery of isoniazid and rifampin. Carbohydrate Polymers 197, pages 403-413.
Crossref
Crossref
Dalia M. Kabary, Maged W. Helmy, Elsayeda-Zeinab A. Abdelfattah, Jia-You Fang, Kadria A. Elkhodairy & Ahmed O. Elzoghby. (2018) Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma. European Journal of Pharmaceutics and Biopharmaceutics 130, pages 152-164.
Crossref
Crossref
Oluwatoyin A. Adeleke, Pei-Chin Tsai, Krizia M. Karry, Nkwe O. Monama & Bozena B. Michniak-Kohn. (2018) Isoniazid-loaded orodispersible strips: Methodical design, optimization and in vitro-in silico characterization. International Journal of Pharmaceutics 547:1-2, pages 347-359.
Crossref
Crossref
Tulshidas S. Patil & Ashwini S. Deshpande. (2018) Nanostructured lipid carriers-based drug delivery for treating various lung diseases: A State‐of‐the‐Art Review. International Journal of Pharmaceutics 547:1-2, pages 209-225.
Crossref
Crossref
Alejandro Nieto-Orellana, David Coghlan, Malcolm Rothery, Franco H. Falcone, Cynthia Bosquillon, Nick Childerhouse, Giuseppe Mantovani & Snow Stolnik. (2018) Dry-powder formulations of non-covalent protein complexes with linear or miktoarm copolymers for pulmonary delivery. International Journal of Pharmaceutics 540:1-2, pages 78-88.
Crossref
Crossref
Piyush Mehta. (2018) Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering. Journal of Drug Delivery 2018, pages 1-19.
Crossref
Crossref
Rajesh Jain, Hemali Savla, Isha Naik, Jinesh Maniar, Kapil Punjabi, Shashikant Vaidya & Mala Menon. 2018. Handbook of Nanomaterials for Industrial Applications. Handbook of Nanomaterials for Industrial Applications
587
620
.
Zimeng Wang & Samantha A. Meenach. (2017) Optimization of Acetalated Dextran–Based Nanocomposite Microparticles for Deep Lung Delivery of Therapeutics via Spray-Drying. Journal of Pharmaceutical Sciences 106:12, pages 3539-3547.
Crossref
Crossref
Michael Y.T. Chow, Yingshan Qiu, Fiona F.K. Lo, Hinson H.S. Lin, Hak-Kim Chan, Philip C.L. Kwok & Jenny K.W. Lam. (2017) Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer. International Journal of Pharmaceutics 530:1-2, pages 40-52.
Crossref
Crossref
Joana Costa-Gouveia, José A. Aínsa, Priscille Brodin & Ainhoa Lucía. (2017) How can nanoparticles contribute to antituberculosis therapy?. Drug Discovery Today 22:3, pages 600-607.
Crossref
Crossref
Lalit Kumar, Shivani Verma, Bhuvaneshwar Vaidya & Neelesh K. Mehra. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy
293
324
.
Sanketkumar Pandya, Anuradha Gupta, Rajeev Ranjan, Madhur Sachan, Atul Kumar Agrawal & Amit Misra. 2016. Drug Delivery Systems for Tuberculosis Prevention and Treatment. Drug Delivery Systems for Tuberculosis Prevention and Treatment
213
238
.
Loïc Bugnicourt & Catherine Ladavière. (2016) Interests of chitosan nanoparticles ionically cross-linked with tripolyphosphate for biomedical applications. Progress in Polymer Science 60, pages 1-17.
Crossref
Crossref
Thaigarajan Parumasivam, Rachel Yoon Kyung Chang, Sharif Abdelghany, Tian Tian Ye, Warwick John Britton & Hak-Kim Chan. (2016) Dry powder inhalable formulations for anti-tubercular therapy. Advanced Drug Delivery Reviews 102, pages 83-101.
Crossref
Crossref
Ana Costa, Marina Pinheiro, Joana Magalhães, Ricardo Ribeiro, Vitor Seabra, Salette Reis & Bruno Sarmento. (2016) The formulation of nanomedicines for treating tuberculosis. Advanced Drug Delivery Reviews 102, pages 102-115.
Crossref
Crossref
Limei Zhang, Ying Li, Yun Zhang & Chunyan Zhu. (2016) Sustained release of isoniazid from polylactide microspheres prepared using solid/oil drug loading method for tuberculosis treatment. Science China Life Sciences 59:7, pages 724-731.
Crossref
Crossref
Nazrul Islam & Vito Ferro. (2016) Recent advances in chitosan-based nanoparticulate pulmonary drug delivery. Nanoscale 8:30, pages 14341-14358.
Crossref
Crossref
Amit Kumar Goyal, Tarun Garg, Goutam Rath, Umesh Datta Gupta & Pushpa Gupta. (2015) Development and Characterization of Nanoembedded Microparticles for Pulmonary Delivery of Antitubercular Drugs against Experimental Tuberculosis. Molecular Pharmaceutics 12:11, pages 3839-3850.
Crossref
Crossref
Catherine Ladavière & Ruxandra Gref. (2015) Toward an optimized treatment of intracellular bacterial infections: input of nanoparticulate drug delivery systems. Nanomedicine 10:19, pages 3033-3055.
Crossref
Crossref
Alejandro Sosnik & Katia P. Seremeta. (2015) Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. Advances in Colloid and Interface Science 223, pages 40-54.
Crossref
Crossref
Alexander S. Berezin & Yury A. Skorik. (2015) Chitosan-isoniazid conjugates: Synthesis, evaluation of tuberculostatic activity, biodegradability and toxicity. Carbohydrate Polymers 127, pages 309-315.
Crossref
Crossref
Susana Rodrigues, Clara Cordeiro, Begoña Seijo, Carmen Remuñán-López & Ana Grenha. (2015) Hybrid nanosystems based on natural polymers as protein carriers for respiratory delivery: Stability and toxicological evaluation. Carbohydrate Polymers 123, pages 369-380.
Crossref
Crossref
H. Qin, C.M. Wang, Q.Q. Dong, L. Zhang, X. Zhang, Z.Y. Ma & Q.R. Han. (2015) Preparation and characterization of magnetic Fe3O4–chitosan nanoparticles loaded with isoniazid. Journal of Magnetism and Magnetic Materials 381, pages 120-126.
Crossref
Crossref
Qi (Tony) Zhou, Sharon Shui Yee Leung, Patricia Tang, Thaigarajan Parumasivam, Zhi Hui Loh & Hak-Kim Chan. (2015) Inhaled formulations and pulmonary drug delivery systems for respiratory infections. Advanced Drug Delivery Reviews 85, pages 83-99.
Crossref
Crossref
S. Choudhary & V. Kusum Devi. (2015) Potential of nanotechnology as a delivery platform against tuberculosis: Current research review. Journal of Controlled Release 202, pages 65-75.
Crossref
Crossref
Zhenglin Liang, Rui Ni, Jieyu Zhou & Shirui Mao. (2015) Recent advances in controlled pulmonary drug delivery. Drug Discovery Today 20:3, pages 380-389.
Crossref
Crossref
Nils Poth, Virginia Seiffart, Gerhard Gross, Henning Menzel & Wibke Dempwolf. (2015) Biodegradable Chitosan Nanoparticle Coatings on Titanium for the Delivery of BMP-2. Biomolecules 5:1, pages 3-19.
Crossref
Crossref
Zahra Merchant, Kevin M.G. Taylor, Paul Stapleton, Sana A. Razak, Nitesh Kunda, Iman Alfagih, Khalid Sheikh, Imran Y. Saleem & Satyanarayana Somavarapu. (2014) Engineering hydrophobically modified chitosan for enhancing the dispersion of respirable microparticles of levofloxacin. European Journal of Pharmaceutics and Biopharmaceutics 88:3, pages 816-829.
Crossref
Crossref
José AriasCornelia Vasile, Manuela Nistor & Anca-Maria Cojocariu. 2014. Nanotechnology and Drug Delivery, Volume One. Nanotechnology and Drug Delivery, Volume One
81
141
.
Mohammed M. Mehanna, Salma M. Mohyeldin & Nazik A. Elgindy. (2014) Respirable nanocarriers as a promising strategy for antitubercular drug delivery. Journal of Controlled Release 187, pages 183-197.
Crossref
Crossref
Nadia Abed & Patrick Couvreur. (2014) Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections. International Journal of Antimicrobial Agents 43:6, pages 485-496.
Crossref
Crossref
Paul Zarogoulidis, Ioannis Kioumis, Christos Ritzoulis, Dimitris Petridis, Kaid Darwiche, Konstantinos Porpodis, Dionysis Spyratos, Scott Parrish, Robert Browning, Qiang Li, J. Francis Turner, Lutz Freitag & Konstantinos Zarogoulidis. (2013) New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam. International Journal of Pharmaceutics 455:1-2, pages 182-188.
Crossref
Crossref
Kyonghee Park, Goo Young Jung, Myong-Ki Kim, Mork Soon Park, Yong Kook Shin, Jae-Kwan Hwang & Soon Hong Yuk. (2012) Triptorelin acetate-loaded poly(lactide-co-glycolide) (PLGA) microspheres for controlled drug delivery. Macromolecular Research 20:8, pages 847-851.
Crossref
Crossref
Nibedita Banik, Anowar Hussain, Anand Ramteke, Hemanta K. Sharma & Tarun K. Maji. (2012) Preparation and evaluation of the effect of particle size on the properties of chitosan-montmorillonite nanoparticles loaded with isoniazid. RSC Advances 2:28, pages 10519.
Crossref
Crossref